Mitral regurgitation (MR) is the most common form of valvular heart disease in the United
States, and there are established guidelines for indications for requiring mitral valve …

Aims Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is
associated with increased morbidity and mortality. The effect of transcatheter interventions to …

Background Percutaneous mitral paravalvular leak (PVL) closure techniques are an
effective and safe alternative to surgical treatment, but data regarding long-term outcomes …

Background In patients with symptomatic mitral PVL, successful transcatheter reduction of
the PVL to less than mild is associated with significant improvement in short-and midterm …

Introduction Recognition and evaluation of structural heart disease has become more
common in clinical practice and will continue to grow as the population ages. With the …

Background: A paravalvular leak (PVL) is a complication following valve replacement, which
may lead to heart failure and hemolysis. The aim of this study is to investigate whether the …

This case presentation involves an 80-year-old male with a history of surgically repaired
patent ductus arteriosus and surgical aortic valve replacement due to infective endocarditis …

Transcatheter interventions have become the standard of care for many congenital heart
defects. As with most areas of congenital heart disease management, interventional …

Paravalvular leak (PVL) is defined as regurgitant blood flow through a communication
between an implanted heart valve and the surrounding tissue. Significant leaks following …

Background: Aortic paravalvular leak (APVL) after surgical valve replacement (AVR) is an
ominous complication with a high risk of morbidity and mortality. Approximately 1–5% of …